Concepedia

Ehsan Malek

EM

34

Publications

2.2K

Citations

21

H-Index

2014

Active since

Affiliations

University Hospitals Seidman Cancer Center(Current)

Case Western Reserve University

University Hospitals of Cleveland

Medical College of Wisconsin

Memorial Sloan Kettering Cancer Center

Ehsan Malek is an author at University Hospitals Seidman Cancer Center specializing in medicine, hematology, and oncology.

ORCID

Top concepts

Publications per year

2014–2024

34

Publications

34

Outcomes of patients with multiple myeloma refractory to CD38-targeted monoclonal antibody therapy

Ujjawal H. Gandhi, Robert F. Cornell, Arjun Lakshman et al. · Leukemia · 2019 · 597 citations

, , +5

Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial

María‐Victoria Mateos, Hilary Blacklock, Fredrik Schjesvold et al. · The Lancet Haematology · 2019 · 249 citations · Full text

, , +6

NCCN Guidelines Insights: Multiple Myeloma, Version 3.2018

Shaji Kumar, Natalie S. Callander, Melissa Alsina et al. · Journal of the National Comprehensive Cancer Network · 2018 · 203 citations · Full text

, , +10

NCCN Guidelines Insights: Multiple Myeloma, Version 1.2020

Shaji Kumar, Natalie S. Callander, Jens Hillengaß et al. · Journal of the National Comprehensive Cancer Network · 2019 · 169 citations · Full text

, , +10

Pharmacologic screens reveal metformin that suppresses GRP78-dependent autophagy to enhance the anti-myeloma effect of bortezomib

Sajjeev Jagannathan, M A Y Abdel-Malek, Ehsan Malek et al. · Leukemia · 2015 · 109 citations · Full text

, , +20

Rows per page

1–5 of 34